Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat
- PMID: 11778847
- DOI: 10.1179/135100001101536436
Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat
Abstract
This study was undertaken to investigate the nitric oxide synthase (NOS) activity in the striatum following 6-hydroxydopamine (6-OHDA) induced neurodegeneration in rats. Constitutive NOS (cNOS) activity remained unaltered at 3, 7 and 14 days after lesion, while a 43% and 45% decrease was observed at 30 and 50 days, respectively. Inducible NOS (iNOS) activity was detected only on the 3rd day after lesion and not in subsequent days or the control striatum. N(G)-nitro-L-arginine methyl ester (L-NAME) pretreatment blocked the amphetamine-induced rotations and inhibited the iNOS activity at the 3rd day after the 6-OHDA injection. L-NAME pretreatment also significantly restored the striatal dopamine (DA), dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels in 6-OHDA treated rats. Thus a possible role of nitric oxide in 6-OHDA induced neurodegeneration is suggested.
Similar articles
-
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.Behav Brain Res. 2004 May 5;151(1-2):191-9. doi: 10.1016/j.bbr.2003.08.016. Behav Brain Res. 2004. PMID: 15084435
-
Nitric oxide regulates NMDA-induced dopamine release in rat striatum.Neuroreport. 1996 Jan 31;7(2):605-8. doi: 10.1097/00001756-199601310-00055. Neuroreport. 1996. PMID: 8730840
-
Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.J Pharmacol Exp Ther. 1997 Feb;280(2):941-7. J Pharmacol Exp Ther. 1997. PMID: 9023310
-
The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention.Drugs Aging. 1998 Apr;12(4):251-9. doi: 10.2165/00002512-199812040-00001. Drugs Aging. 1998. PMID: 9571390 Review.
-
Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?Mol Neurobiol. 2014 Feb;49(1):262-75. doi: 10.1007/s12035-013-8517-4. Epub 2013 Jul 31. Mol Neurobiol. 2014. PMID: 23900742 Review.
Cited by
-
The Effects of Crocin on 6-OHDA-Induced Oxidative/Nitrosative Damage and Motor Behaviour in Hemiparkinsonian Rats.Malays J Med Sci. 2016 Nov;23(6):35-43. doi: 10.21315/mjms2016.23.6.4. Epub 2016 Dec 7. Malays J Med Sci. 2016. PMID: 28090177 Free PMC article.
-
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.AAPS J. 2006 Sep 29;8(3):E606-21. doi: 10.1208/aapsj080369. AAPS J. 2006. PMID: 17025278 Free PMC article. Review.
-
The S-nitrosylation status of PCNA localized in cytosol impacts the apoptotic pathway in a Parkinson's disease paradigm.PLoS One. 2015 Feb 12;10(2):e0117546. doi: 10.1371/journal.pone.0117546. eCollection 2015. PLoS One. 2015. PMID: 25675097 Free PMC article.
-
Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders-An Overview.Antioxidants (Basel). 2023 Mar 20;12(3):753. doi: 10.3390/antiox12030753. Antioxidants (Basel). 2023. PMID: 36979000 Free PMC article. Review.
-
Nitric Oxide-Soluble Guanylyl Cyclase-Cyclic GMP Signaling in the Striatum: New Targets for the Treatment of Parkinson's Disease?Front Syst Neurosci. 2011 Jun 30;5:55. doi: 10.3389/fnsys.2011.00055. eCollection 2011. Front Syst Neurosci. 2011. PMID: 21747761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical